Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 71610-022, ATORVASTATIN CALCIUM, tablet, film coated, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-022
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090548
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
71610-022-457161000224545 TABLET, FILM COATED in 1 BOTTLE (71610-022-45)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0b4f1a2-0082-4150-8f2b-e7440252b675

Use it

Look up 71610-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.